Skip to content
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
  • June 13, 2016

All in on cancer immunotherapy

  • for BioVox
  • June 13, 2016

Afraid you might have an STD? Test it with DirectLab!

  • for BioVox
  • June 9, 2016

New US adventure for ThromboGenics’ JETREA?

  • for BioVox
  • June 8, 2016

Solving the C-mystery

  • for BioVox
  • June 7, 2016

Essenscia/bio.be organizes Dermira and JLABS visits during Bio US!

  • for BioVox
  • June 7, 2016

Fresh money for llama biotech

  • for BioVox
  • June 6, 2016

Strong Belgian presence at Bio US

  • for BioVox
  • June 2, 2016

Bridge2Health: the new link in the Belgian biotech chain

  • for BioVox
  • June 1, 2016

Biocartis’ Ebola test approved for emergency use

  • for BioVox
  • May 31, 2016

New type of cod can be cultured in Belgium!

  • for BioVox
  • May 31, 2016

White Paper on In Vitro Diagnostics – Belgium: R&D hotspot

  • for BioVox
  • May 24, 2016

Patent discussion knocks down UCB shares

  • for BioVox
  • May 24, 2016

Japan pledges $130M to infectious disease fund

  • for BioVox
  • May 19, 2016

Hep C drug also active against zika

  • for BioVox
  • May 19, 2016

23,5 million euro for a cutting-edge allergy treatment

  • for BioVox
Previous Next

Follow us on

Icon-linkedin Facebook Icon-x Instagram

Stay updated on the latest news!

Subscribe

Want to contact us?

Contact

Interested in our media kit?

Media kit

Stay updated on the latest news!

Subscribe

Want to get in touch?

Contact Us

Follow us on

Icon-linkedin
©2026 BioVox. All rights reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}